Trials / Completed
CompletedNCT00116103
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine the safety and effectiveness of tacrolimus inhalation aerosol in subjects with persistent asthma.
Detailed description
The purpose of this randomized, double-blind, placebo-controlled, parallel-group, multi-center designed trial is to determine the safety and efficacy of tacrolimus inhalation aerosol in subjects with persistent asthma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus Inhalation Aerosol |
Timeline
- Start date
- 2005-06-01
- Completion
- 2006-04-01
- First posted
- 2005-06-28
- Last updated
- 2012-06-07
Locations
21 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00116103. Inclusion in this directory is not an endorsement.